Key Finding
Traditional Chinese Medicine compounds and monomers can ameliorate rheumatoid arthritis symptoms by modulating macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotypes.
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes painful inflammation in joints and other body systems, often leading to disability. Current medications can be effective but frequently cause serious side effects with long-term use, making safer treatment options highly desirable. This review study examined how Traditional Chinese Medicine (TCM) might help treat RA through a specific immune mechanism involving macrophages—white blood cells that play key roles in inflammation and healing.
Researchers analyzed recent scientific studies exploring how macrophages behave in rheumatoid arthritis. They found that these immune cells can transform into different types depending on their environment, a process called "polarization." In RA, macrophages often polarize into inflammatory types that worsen joint damage. However, certain TCM compounds and herbal ingredients appear to influence this polarization process, shifting macrophages toward anti-inflammatory types that help reduce RA symptoms instead.
The review identified that both individual TCM components and herbal formulas show promise in redirecting macrophage behavior to fight inflammation rather than promote it. This mechanism may explain why some traditional treatments help RA patients experience symptom relief. While this study focused on herbal medicine rather than acupuncture specifically, both therapies fall under the TCM umbrella and often work together in clinical practice. The findings suggest that TCM approaches targeting immune cell behavior could offer safer alternatives to conventional medications with fewer toxic side effects.
If you're considering acupuncture or TCM treatment for rheumatoid arthritis, consult with a licensed acupuncturist or integrative medicine specialist who has experience treating autoimmune conditions.
This review examines the therapeutic potential of Traditional Chinese Medicine in rheumatoid arthritis treatment through macrophage polarization mechanisms. The authors analyzed recent literature demonstrating that macrophages recruited to inflamed RA tissues undergo polarization into distinct phenotypes based on local microenvironmental signals. Pathologically, pro-inflammatory M1 macrophages predominate in RA synovium, perpetuating joint destruction. Evidence indicates that TCM monomers and compound formulas can modulate this polarization, shifting the M1/M2 balance toward anti-inflammatory M2 phenotypes, thereby ameliorating RA symptoms. No specific sample sizes or effect sizes were provided as this is a narrative review rather than original research. Clinical significance: This mechanism-focused analysis provides theoretical support for TCM interventions in RA management, particularly herbal formulations. The macrophage polarization pathway represents a promising therapeutic target that may explain TCM's anti-rheumatic efficacy while potentially offering improved safety profiles compared to conventional DMARDs. Consider integrating herbal medicine protocols targeting immune modulation in RA treatment plans.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Modified acupuncture techniques, including electroacupuncture and needle-knife therapy, significantly reduced TNF-α levels in knee osteoarthritis patients compared to traditional acupuncture (SMD = -1.63, p < 0.01), with moderate GRADE evidence supporting this effect.
📌 The Bushen Tongdu external treatment combining full-channel moxibustion and acupoint catgut embedding achieved a 90.6% effective rate in kidney-yang deficiency type ankylosing spondylitis, significantly outperforming salazosulfapyridine on BASDAI scores and serum inflammatory markers IL-6, TNF-α, and MMP-3.
📌 Acupuncture, particularly as adjunct therapy, significantly reduced pain, morning stiffness, and key inflammatory markers including CRP, ESR, and pro-inflammatory cytokines in patients with ankylosing spondylitis across 52 randomized controlled trials.